Mineralys Therapeutics Other Current Assets

Mineralys Therapeutics (MLYS) currently reports a other current assets of $4.4M as of June 2026. That compares with $230M in the prior-year period — down 98.1% year over year. Use the charts on this page to explore Mineralys Therapeutics's other current assets history and peer comparisons.

Mineralys Therapeutics's other current assets decreased from $230M to $4.4M — a 98.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Mineralys Therapeutics reported $4.4M in other current assets as of June 2026. That compares with $230M in the prior-year period — down 98.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $4.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mineralys Therapeutics, and consider following MLYS for alerts when major investors trade the stock.